MS 209
A substance that is being studied for its ability to make cancer cells respond better to chemotherapy drugs to which they have become resistant. It is a type of quinolone antibiotic.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.